
Australia: medical cannabis snapshot, October 2024
1st October 2024 - Market reports , Regulatory reports |
This snapshot offers an overview of Australia’s medical cannabis market and its regulations
This snapshot offers an overview of Australia’s medical cannabis market and its regulations
Thailand’s new government has said it will not reclassify cannabis as an illegal drug as it seeks to end a legal limbo that has chilled investor interest in the country’s nascent weed industry
Some fear healthcare and food safety will not be among the main concerns of the next European Commission after the Commission president unveiled the new commissioners’ respective tasks
Brazilian pharmaceutical company Ease Labs officially announced the acquisition this month of Plena, a cannabis cultivation and extraction company based in Colombia
This snapshot offers an overview of the Poland’s medical cannabis market and its regulations
This snapshot offers an overview of Israel’s medical cannabis market and its regulations
This snapshot offers an overview of Canada’s medical cannabis market and its regulations
CBD company websites must follow UK Food Standards Agency (FSA) guidelines – even though they are recommendations only – as demonstrated by two new rulings from the Advertising Standards Agency (ASA)
The US Fourth Circuit Court of Appeals recently decided tetrahydrocannabinol acetate (THCO) was legal under current federal law, disregarding an interpretation by the Drug Enforcement Administration
This snapshot offers an overview of Switzerland’s medical cannabis market and its regulations
A US federal circuit appeals court has affirmed the legality of “synthetically derived” hemp cannabinoids, rejecting interpretations by the Drug Enforcement Administration (DEA) on intoxicating hemp-derived cannabinoids (IHDCs) in the process
In 2023, nearly a third – around $3.4m – of Colombia’s total cannabis exports went to Brazil, driven by regulatory shifts and Colombia’s determination to dominate the international cannabis market
This short report aims to highlight the most significant changes that have occurred in CannIntelligence’s EU environmental tracker in summer 2024
Democratic US presidential candidate Kamala Harris has become one of the most positive major voices for cannabis liberalisation at the federal level, but critics say her prior record undermines that and leaves her untrustworthy
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
Notifications